Eltrombopag is effective and safe in immune thrombocytopenia (ITP). Some patients may
sustain their platelet response when treatment is withdrawn but the frequency of this …

Background The thrombopoietin receptor agonist romiplostim could be an effective
treatment in symptomatic children with persistent or chronic immune thrombocytopenia. We …

Management of children with newly diagnosed immune thrombocytopenia (ITP) consists of
careful observation or immunomodulatory treatment. Observational studies suggest a lower …

Essentials• Risk factors of bleeding in adult immune thrombocytopenia are not known.• This
multicenter study assessed risk factors of bleeding at immune thrombocytopenia onset.• …

Autoimmune hemolytic anemia (AIHA) is a rare and heterogeneous disease that affects 1 to
3/100 000 patients per year. AIHA caused by warm autoantibodies (w-AIHA), ie, antibodies …

Thrombocytopenia occurs commonly during pregnancy, and may result from diverse
etiologies. Awareness of these many causes facilitates proper diagnosis and management …

Immune thrombocytopenia (ITP) patients with similarly low platelet counts differ in their
tendency to bleed. To determine if differences in platelet function in ITP patients account for …

In this study, we report the results from the largest cohort to date of newly diagnosed adult
immune thrombocytopenia patients randomized to treatment with dexamethasone alone or …

Immune thrombocytopenia (ITP) represents the epitome of acquired bleeding diseases for
the hematologist. Stemming from the interest for the safety of thrombopoietin‐receptor …

Immune thrombocytopenia resulting from antibody-mediated platelet destruction combined
with impaired platelet production is a common cause of thrombocytopenia. The decision to …